AnalystsInsight

Lisa Gill (J.P. Morgan): Analyst Track Record and Price‑Target Accuracy

How often Lisa Gill’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,053 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Lisa Gill ranks #876 of 1,121 analysts in Exent’s scoring (4.6★).
  • 52.5% of price targets were reached over 7 years, versus 53.6% for the average analyst.
  • Median time to reach a target: 118 days; 54.4% of calls were up 12 months later.
  • Most‑covered stocks: UNH, MCK, CAH, CI.
  • Free on Exent: Lisa Gill’s full record, with ratings 3 days after publication.

Lisa Gill’s track record at a glance

Lisa Gill of J.P. Morgan ranks #876 of the 1,121 analysts Exent scores, with a 4.6★ rating and a focus on healthcare. Over a 7‑year lookback, 52.5% of Lisa’s price targets were reached, 1.1 points below the 53.6% average across all analysts.

MetricLisa GillAll analysts
Price‑target hit rate52.5%53.6%
Median days to hit target118 days91 days
Calls up after 12 months54.4%64.6%
Median 12‑month return of calls+5.3%+13.4%
Hit rate, last 2 years55.1%—
Average worst drop after a call−22.8%—
Ratings in the sample1,053—
Stocks covered36—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetLisa Gill
Under 30 days17.0%
30–90 days21.7%
90–180 days28.7%
Over 180 days32.6%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Lisa Gill covers most

StockRatings in the sample
UNH42
MCK26
CAH25
CI25
LH23
OPCH22
ELV22
CVS21

In the past year Lisa’s ratings were 65% Buy, 34% Hold and 1% Sell.

Lisa Gill’s latest ratings

DateStockActionRatingPrice target
Oct 16, 2026UNHReiterated: BuyBuy$524.00
Oct 12, 2026OPCHDowngraded: HoldHold$33.00
Oct 7, 2026OPCHDowngraded: HoldHold$33.00
Aug 26, 2026LHReiterated: BuyBuy$0.00
Aug 24, 2026AGLReiterated: SellSell$85.00
Aug 21, 2026PGNYReiterated: HoldHold$30.00
Aug 17, 2026CAHReiterated: HoldHold$260.00
Aug 14, 2026OMDAReiterated: BuyBuy$30.00
Aug 14, 2026LFSTReiterated: HoldHold$13.00
Aug 13, 2026CAHRated: HoldHold$260.00
Aug 12, 2026MDLNReiterated: BuyBuy$46.00
Aug 12, 2026CVSReiterated: BuyBuy$118.00
  • Oct 16, 2026
    Stock
    UNH
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $524.00
  • Oct 12, 2026
    Stock
    OPCH
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $33.00
  • Oct 7, 2026
    Stock
    OPCH
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $33.00
  • Aug 26, 2026
    Stock
    LH
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00
  • Aug 24, 2026
    Stock
    AGL
    Action
    Reiterated: Sell
    Rating
    Sell
    Price target
    $85.00
  • Aug 21, 2026
    Stock
    PGNY
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $30.00
  • Aug 17, 2026
    Stock
    CAH
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $260.00
  • Aug 14, 2026
    Stock
    OMDA
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $30.00
  • Aug 14, 2026
    Stock
    LFST
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $13.00
  • Aug 13, 2026
    Stock
    CAH
    Action
    Rated: Hold
    Rating
    Hold
    Price target
    $260.00
  • Aug 12, 2026
    Stock
    MDLN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $46.00
  • Aug 12, 2026
    Stock
    CVS
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $118.00

Lisa’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 21, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Lisa Gill’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Lisa Gill ranks #876 of 1,121 with a 4.6★ rating. 52.5% of price targets were reached over a 7-year lookback (all analysts: 53.6%), and 54.4% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Lisa Gill’s success rate is 60.9% by the ranking source and 52.5% by Exent’s price-target hit-rate backtest, with a median of 118 days to reach a target.

Lisa Gill (J.P. Morgan) covers 36 stocks, mostly in healthcare. The most frequently rated are UNH, MCK, CAH, CI, LH.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.